Skip to main content
logo
Ashok Leyland Limited (NSE:ASHOKLEY)
India flag India · Delayed Price · Currency is INR
120.35
-0.70 (-0.58%)
Aug 1, 2025, 3:30 PM IST

CTI BioPharma Revenue

In the fiscal year ending March 31, 2025, Ashok Leyland had annual revenue of 485.35B INR with 6.20% growth. Ashok Leyland had revenue of 146.96B in the quarter ending March 31, 2025, with 8.93% growth.

Revenue
485.35B
Revenue Growth
+6.20%
P/S Ratio
1.46
Revenue / Employee
50.06M
Employees
9,695
Market Cap
706.82B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025485.35B28.32B6.20%
Mar 31, 2024457.03B40.31B9.67%
Mar 31, 2023416.73B154.35B58.83%
Mar 31, 2022262.37B67.83B34.87%
Mar 31, 2021194.54B-24.97B-11.38%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Hindustan Aeronautics309.81B
Adani Ports and Special Economic Zone304.75B
InterGlobe Aviation817.29B
Mazagon Dock Shipbuilders117.00B
Siemens222.24B
CG Power and Industrial Solutions105.59B
Polycab India236.16B
GMR Airports112.17B
Revenue Rankings

Ashok Leyland News

More News